| Product Name | Lercanidipine hydrochloride | 
|---|---|
| CAS | 132866-11-6 | 
| Formula | C36H42ClN3O6 | 
| MW | 648.19 | 
| MDL | MFCD07773089 | 
| Appearance | Light yellow to yellow powder | 
| Storage condition | 4°C, sealed storage, away from moisture | 
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | |
|---|---|---|---|---|---|
| 
                                             There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.  | 
                                    |||||
| Product Name | Lercanidipine hydrochloride | 
|---|---|
| CAS | 132866-11-6 | 
| Formula | C36H42ClN3O6 | 
| MW | 648.19 | 
| MDL | MFCD07773089 | 
| Appearance | Light yellow to yellow powder | 
| Storage condition | 4°C, sealed storage, away from moisture | 
Lercanidipine, a third-generation dihydropyridine calcium channel blocker, exhibits a pIC50 of 7.74 and features lipophilicity, brain penetration, and vascular selectivity . It demonstrates sustained antihypertensive effects, along with reno- and neuroprotection, and possesses antioxidant, anti-inflammatory, and anti-apoptotic properties, making it relevant for cardiovascular and neurological research.
Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
Exp Neurol. 2017 Feb;288:25-37.
Calcium Channel Blockers--Benefits Upon Vascular Biology in Hypertensive Patients.
PMID: 26245661 DOI: 10.2174/187152571301150730115442
PMID: 23290263 DOI: 10.1016/j.atherosclerosis.2012.12.005